169 related articles for article (PubMed ID: 32421920)
41. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
[TBL] [Abstract][Full Text] [Related]
43. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
44. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
45. Myoepithelial cell layer integrity in canine mammary carcinoma.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
[TBL] [Abstract][Full Text] [Related]
46. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
47. Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
Ryu JE; Park HK; Choi HJ; Lee HB; Lee HJ; Lee H; Yu ES; Son WC
Vet Comp Oncol; 2018 Jun; 16(2):239-245. PubMed ID: 29266697
[TBL] [Abstract][Full Text] [Related]
48. A statistical assessment of the biological relationship between simultaneous canine mammary tumours.
Gunnes G; Borge KS; Lingaas F
Vet Comp Oncol; 2017 Jun; 15(2):355-365. PubMed ID: 26452754
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma.
Levi M; Brunetti B; Sarli G; Benazzi C
J Comp Pathol; 2016 Nov; 155(4):277-285. PubMed ID: 27528038
[TBL] [Abstract][Full Text] [Related]
50. Understanding of tumourigenesis in canine mammary tumours based on cancer stem cell research.
Michishita M
Vet J; 2020 Nov; 265():105560. PubMed ID: 33129557
[TBL] [Abstract][Full Text] [Related]
51. Haemoglobin in normal and neoplastic canine mammary glands.
Chang SC; Chen HF; Chou MH; Wang HC; Su HY; Wong ML
Vet Comp Oncol; 2010 Dec; 8(4):302-9. PubMed ID: 21062412
[TBL] [Abstract][Full Text] [Related]
52. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
56. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
57. Establishment of primary mixed cell cultures from spontaneous canine mammary tumors: Characterization of classic and new cancer-associated molecules.
Gentile LB; Nagamine MK; Biondi LR; Sanches DS; Toyota F; Giovani TM; de Jesus IP; da Fonseca IIM; Queiroz-Hazarbassanov N; Diaz BL; Salles Gomes COM; Dagli MLZ
PLoS One; 2017; 12(9):e0184228. PubMed ID: 28945747
[TBL] [Abstract][Full Text] [Related]
58. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
59. Cellular sources of tenascin-C in canine mammary carcinomas.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Matsuda Y; Ishiwata T; Naito Z; Takahashi K
Vet Pathol; 2015 Jan; 52(1):92-6. PubMed ID: 24565830
[TBL] [Abstract][Full Text] [Related]
60. Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features.
Estrela-Lima A; Araújo MS; Soares RP; Ribeiro LG; Damasceno KA; Costa AT; Teixeira-Carvalho A; Martins-Filho OA; Cassali GD
Vet Comp Oncol; 2016 Mar; 14(1):88-100. PubMed ID: 24571435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
